Study to Learn How the Drug Aflibercept Works in in Japanese Patients With Increased Eye Pressure That is Caused by New Blood Vessels Growing in the Eye (Neovascular Glaucoma or NVG). Safety of the Drug and Patients' Tolerability of the Drug Injection is Also Studied — VENERA

Glaucoma, Neovascular Clinical Trial

Official title:
A Single-arm, Non-randomized and Open-label Phase 3 Study Evaluating the Efficacy, Safety and Tolerability of Intravitreal Aflibercept in Japanese Patients With Neovascular Glaucoma (NVG)

Status Completed

Clinical Trial Summary

The researchers in this trial want to learn how the drug aflibercept works in in Japanese patients with increased eye pressure that is caused by new blood vessels growing in the eye (neovascular glaucoma or NVG). They also want to find out how patient tolerate the application of the drug that is injected in the vitreous humor of the eye and if this will cause any medical problems during the trial (vitreous humor, also called vitreous body is the clear gel that fills the space between the lens and the retina of the eyeball).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03639675
Study type	Interventional
Source	Bayer
Contact
Status	Completed
Phase	Phase 3
Start date	October 3, 2018
Completion date	March 14, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01908816` - An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.	Phase 3
Not yet recruiting	`NCT02914626` - Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study	Phase 3
Not yet recruiting	`NCT05593354` - MicroPulse TLT - UK Study
Completed	`NCT03187418` - Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled Glaucoma	N/A
Completed	`NCT02647515` - Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma	Phase 4
Enrolling by invitation	`NCT04381611` - INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predictors Analysed From a Large-scale Retrospective and Prospective Glaucoma Register
Completed	`NCT04215575` - Baerveldt (BGI) Valve Versus Ahmed(AGV) Valve in Management of Difficult Glaucoma Cases	N/A
Completed	`NCT01922154` - Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma	Phase 4
Completed	`NCT04214847` - The Outcome of Ahmed Glaucoma Valve in Difficult Glaucoma Cases	N/A
Recruiting	`NCT03648814` - Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT	N/A
Completed	`NCT02396316` - Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients	Phase 3